GB0306329D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0306329D0
GB0306329D0 GBGB0306329.4A GB0306329A GB0306329D0 GB 0306329 D0 GB0306329 D0 GB 0306329D0 GB 0306329 A GB0306329 A GB 0306329A GB 0306329 D0 GB0306329 D0 GB 0306329D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0306329.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0306329.4A priority Critical patent/GB0306329D0/en
Publication of GB0306329D0 publication Critical patent/GB0306329D0/en
Priority to PCT/EP2004/002831 priority patent/WO2004083185A2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0306329.4A 2003-03-19 2003-03-19 Compounds Ceased GB0306329D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0306329.4A GB0306329D0 (en) 2003-03-19 2003-03-19 Compounds
PCT/EP2004/002831 WO2004083185A2 (en) 2003-03-19 2004-03-17 Phenyl substituted imidazole derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0306329.4A GB0306329D0 (en) 2003-03-19 2003-03-19 Compounds

Publications (1)

Publication Number Publication Date
GB0306329D0 true GB0306329D0 (en) 2003-04-23

Family

ID=9955103

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0306329.4A Ceased GB0306329D0 (en) 2003-03-19 2003-03-19 Compounds

Country Status (2)

Country Link
GB (1) GB0306329D0 (en)
WO (1) WO2004083185A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0323585D0 (en) * 2003-10-08 2003-11-12 Glaxo Group Ltd Compounds
DE602004011966T2 (en) * 2003-10-24 2009-02-12 Glaxo Group Ltd., Greenford heterocyclyl
WO2006066968A1 (en) 2004-12-23 2006-06-29 Glaxo Group Limited Pyridine compounds for the treatment of prostaglandin mediated diseases
GB0606876D0 (en) * 2006-04-05 2006-05-17 Glaxo Group Ltd Compounds
EP2314587A4 (en) 2008-07-17 2012-01-25 Asahi Kasei Pharma Corp Nitrogenated heterocyclic compound
JPWO2010007944A1 (en) 2008-07-17 2012-01-05 旭化成ファーマ株式会社 Nitrogenous bicyclic heterocyclic compounds
EP2570125A1 (en) * 2011-09-16 2013-03-20 Almirall, S.A. Ep1 receptor ligands
SG11201700777VA (en) 2014-08-04 2017-02-27 Nuevolution As Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases
MX2022007265A (en) 2019-12-20 2022-09-09 Nuevolution As Compounds active towards nuclear receptors.
WO2021198955A1 (en) 2020-03-31 2021-10-07 Nuevolution A/S Compounds active towards nuclear receptors
JP2023519605A (en) 2020-03-31 2023-05-11 ヌエヴォリューション・アクティーゼルスカブ Compounds active against nuclear receptors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1216238B1 (en) * 1999-09-14 2004-02-18 Merck Frosst Canada & Co. Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
ES2159489B1 (en) * 2000-03-23 2002-04-16 Uriach & Cia Sa J NEW IMIDAZOL DERIVATIVES WITH ANTI-INFLAMMATORY ACTIVITY.
WO2002015902A1 (en) * 2000-08-23 2002-02-28 Merck & Co., Inc. Method of treating or preventing urinary incontinence using prostanoid ep1 receptor antagonists
GB0212785D0 (en) * 2002-05-31 2002-07-10 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
WO2004083185A3 (en) 2004-11-04
WO2004083185A2 (en) 2004-09-30

Similar Documents

Publication Publication Date Title
GB0309781D0 (en) Compounds
GB0316915D0 (en) Compounds
GB0315950D0 (en) Compounds
GB0305559D0 (en) Compounds
GB0317268D0 (en) Compounds
GB0314476D0 (en) Compounds
GB0314479D0 (en) Compounds
GB0314478D0 (en) Compounds
EP1689403A4 (en) Heteroaryl-hydrazone compounds
GB0304665D0 (en) Compounds
GB0305553D0 (en) Compounds
GB0313915D0 (en) Compounds
GB0323585D0 (en) Compounds
GB0313914D0 (en) Compounds
EP1658301A4 (en) N-desmethyl-n-substituted-11-deoxyerythromycin compounds
EP1682514A4 (en) 11- o-methylgeldanamycin compounds
GB0304494D0 (en) Compounds
GB0302512D0 (en) Compounds
GB0317269D0 (en) Compounds
GB0304492D0 (en) Compounds
GB0312356D0 (en) Compounds
GB0307998D0 (en) Compounds
GB0308017D0 (en) Compounds
GB0308105D0 (en) Compounds
GB0309326D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)